Acupuncture treatment of lung-spleen Qi deficiency in stable chronic obstructive pulmonary disease: a randomized, open-label, controlled trial

被引:0
|
作者
Li Yu [1 ]
Xiong Chan [1 ]
Zeng Yan [1 ]
Wei Hua [1 ]
Zhuang Guangtong [2 ]
Zhao Lihong [1 ]
Li Chenyi [1 ]
Li Lin [3 ]
Qin Erqi [3 ]
Chen Xiaoqin [3 ]
Fu Juanjuan [4 ]
机构
[1] Respiratory Department,No.3 Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (West District),Chengdu Pidu District Hospital of Traditional Chinese Medicine
[2] Department of Integrated Traditional and Western Medicine,West China Hospital,Sichuan University
[3] Cardiovascular Department,No.3 Affiliated Hospital of Chengdu University of Traditional Chinese Medicine(West District),Chengdu Pidu District Hospital of Traditional Chinese Medicine
[4] Department of Research,No.3 Affiliated Hospital of Chengdu University of Traditional Chinese Medicine (West District),Chengdu Pidu District Hospital of Traditional Chinese Medicine
关键词
Acupuncture; Pulmonary disease; chronic obstructive; Randomized controlled trial; Symptoms and signs;
D O I
10.19852/j.cnki.jtcm.2019.06.016
中图分类号
R563.9 [其他];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE: To evaluate the effectiveness and safety of acupuncture that reinforces the spleen to strengthen the lung in patients with stable chronic obstructive pulmonary disease(COPD).METHODS: This was a randomized, open-controlled trial in which the acupuncturist and the participants were not blinded, but the outcome evalu-ators and data analysts were blinded. One-hundred-and-two patients with stable COPD were randomly divided into two groups in a 1∶1 ratio. The acupuncture group received 30-minute sessions of acupuncture therapy at the same acupoints three times weekly for 6 weeks in addition to routine conventional Western Medicine treatment; the control group received routine conventional Western Medicine treatment alone. The primary outcome was the Borg scale score, which was assessed immediately after the 6-minute walk test. The secondary outcomes were the 6-minute walk distance, lung function, and oxygen saturation. Measurements were obtained at baseline and after 6 weeks of treatment.RESULTS: After 6 weeks of treatment, the Borg scale score in the acupuncture group was significantly better than that in the control group(2.02 ±0.71 versus 5.01 ± 0.34, P < 0.05). Furthermore, the post-treatment improvements in the 6-minute walk distance, lung function, and oxygen saturation were significantly greater in the acupuncture group than in the control group, showing that the acupuncture group had better exercise tolerance.CONCLUSION: The findings suggest that acupuncture that aims to reinforce the spleen to strengthen the lung is a safe and effective adjuvant therapy that effectively improves the exercise capacity of patients with stable COPD.
引用
收藏
页码:885 / 891
页数:7
相关论文
共 50 条
  • [41] Acupuncture Treatment of Delirium in Older Adults Hospitalized in Internal Medicine Departments: An Open-Label Pragmatic Randomized-Controlled Trial
    Levy, Ilana
    Gavrieli, Sagi
    Hefer, Talia
    Attias, Samuel
    Schiff, Ariel
    Oliven, Ron
    Wisberg-Levi, Shikma
    Hanchinsky, Rina
    Schiff, Elad
    JOURNAL OF GERIATRIC PSYCHIATRY AND NEUROLOGY, 2022, 35 (03) : 333 - 343
  • [42] Comparison of the efficacy and tolerability of mepifylline oral solution versus inhaled ipratropium bromide in patients with stable chronic obstructive pulmonary disease: A randomized, active-controlled, open-label study
    Sampablo, I
    Sueiro, A
    Burgos, A
    Moreno, E
    CURRENT THERAPEUTIC RESEARCH-CLINICAL AND EXPERIMENTAL, 2002, 63 (02): : 110 - 127
  • [43] Costs and benefits of Pulmonary Rehabilitation in Chronic Obstructive Pulmonary Disease: a randomized controlled trial
    Farias, Catharinne C.
    Resqueti, Vanessa
    Dias, Fernando A. L.
    Borghi-Silva, Audrey
    Arena, Ross
    Fregonezi, Guilherme A. F.
    BRAZILIAN JOURNAL OF PHYSICAL THERAPY, 2014, 18 (02) : 165 - 173
  • [44] Efficacy and cerebral mechanisms of acupuncture for chronic obstructive pulmonary disease: study protocol for a multicenter, randomized controlled neuroimaging trial
    Chen, Xugui
    Xiong, Chan
    Xiao, Wei
    Du, Longyi
    Liu, Meilu
    Yu, Yan
    Liao, Chunyu
    Zhang, Chengshun
    Li, Yu
    Mao, Bing
    Fu, Juanjuan
    FRONTIERS IN NEUROLOGY, 2024, 15
  • [45] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, Uri
    Carmeli, Gal
    Chalamish, Yossi
    Braw, Yoram
    Kirsch, Irving
    Shefet, Daphna
    Krieger, Israel
    Mendlovic, Shlomo
    Bloch, Yuval
    Lichtenberg, Pesach
    JOURNAL OF AFFECTIVE DISORDERS, 2020, 276 : 707 - 710
  • [46] Role of doxycycline in the treatment of dengue infection: An open-label, randomized, controlled, pilot trial
    Kumar, Banothu Vinod
    Kamboj, Kajal
    Pannu, Ashok Kumar
    Yadav, Ashok Kumar
    Bhatia, Mandip
    Saroch, Atul
    ASIAN PACIFIC JOURNAL OF TROPICAL MEDICINE, 2024, 17 (04) : 160 - 165
  • [47] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, U.
    EUROPEAN PSYCHIATRY, 2023, 66 : S845 - S846
  • [48] Open-Label placebo for the treatment of unipolar depression: Results from a randomized controlled trial
    Nitzan, U.
    EUROPEAN PSYCHIATRY, 2023, 66 : S845 - S846
  • [49] An open-label randomized controlled trial of lactulose and probiotics in the treatment of minimal hepatic encephalopathy
    Sharma, Praveen
    Sharma, Barjesh C.
    Puri, Vinod
    Sarin, Shiv Kumar
    EUROPEAN JOURNAL OF GASTROENTEROLOGY & HEPATOLOGY, 2008, 20 (06) : 506 - 511
  • [50] Phenobarbitone versus Phenytoin for Treatment of Neonatal Seizures: An Open-label Randomized Controlled Trial
    Pathak, Garima
    Upadhyay, Amit
    Pathak, Umesh
    Chawla, Deepak
    Goel, Sneh P.
    INDIAN PEDIATRICS, 2013, 50 (08) : 753 - 757